Search PDMR transactions

Notifier
Name of person with notification obligation
Johan Living
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Johan Living
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Lipigon Pharmaceuticals AB SE0015382072 Acquisition 260,000 Quantity 0.1988 SEK 16/12/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB SE0015382072 Acquisition 16/12/2024 NASDAQ STOCKHOLM AB 260,000 (Quantity) 0.1988 SEK
Total: 260,000
<< Back